Ashly Elizabeth Joseph, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 11731 Pointe Pl, Roswell, GA 30076 Phone: 770-284-3150 Fax: 770-284-3170 |
John Chip Hamilton Reed Iii, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1475 Holcomb Bridge Rd, Suite 129, Roswell, GA 30076 Phone: 678-325-2250 Fax: 678-325-2261 |
Arjun Haridas, Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1475 Holcomb Bridge Rd Ste 129, Roswell, GA 30076 Phone: 678-325-2250 |
News Archive
Ovarian cancer is a rare but often deadly disease that can strike at any time in a woman's life. It affects one in 70 women and in the past was referred to as a silent killer, but researchers have found there are symptoms associated with ovarian cancer that can assist in early detection. Experts at Northwestern Memorial say the best defense is to make use of preventive methods, understand the risks and recognize potential warning signs of ovarian cancer.
​Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC), these trials have predominantly compared different chemotherapy regimens rather than comparing chemotherapy to best supportive care. Some of them included chest radiation or prophylactic cranial irradiation. Moreover, many trials excluded elderly patients.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technologyâ„¢ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
A noted authority in health services research, critical care and geriatric medicine, Dr. Marc D. Silverstein has been appointed chairman of a newly created Department of Public Health at The Methodist Hospital in Houston.
› Verified 2 days ago